Long term treatment with omalizumab in adolescent with refractory solar urticaria

• Main Authors: Mauro Iannelli (Author), Stefano Passanisi (Author), Giuseppe Crisafulli (Author), Stefania Arasi (Author), Lucia Caminiti (Author), Giuseppina Zirilli (Author), Giovanni B. Pajno (Author)
• Format: Book
• Published: BMC, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Solar urticaria represents an uncomfortable form of chronic inducible urticaria. First and second-line treatments are ineffective in some patients, leading to an impairment in their quality of life. Omalizumab represents a safe therapeutic option in case of refractory solar urtic...